University of Pennsylvania 6th annual conference on statistical issues in clinical trials: Dynamic treatment regimes (morning session)

Abstract

Get full access to this article

View all access options for this article.

References

Almirall

Lizotte

Murphy

. SMART Design issues and the consideration of opposing outcomes. Discussion of ‘Evaluation of viable dynamic treatment regimes in a sequentially randomized trial of advanced prostate cancer’ by Wang, Rotnitzky, Lin, Millikan, and Thall. J Am Stat Assoc 2012; 107: 509–12 (PMCID: PMC3607391).

Chakraborty

Laber

Zhao

. Inference for optimal dynamic treatment regimes using an adaptive m-out-of-n bootstrap scheme. Biometrics 2013; 69(3): 714–23 (PMCID: PMC3864701).

Laber

Lizotte

Ferguson

. Set-valued dynamic treatment regimes for competing outcomes. Biometrics 2014; 70: 53–61 (PMCID: PMC3954452).

Habermann

Weller

Morrison

. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large b-cell lymphoma. J Clin Oncol 2006; 24: 3121–27 (PMID: 16754935).